Tessera Therapeutics, Inc.
Somerville, MA
- UEI
- XFPJKGA6ARL1
- CAGE
- 9WU32
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 101 South St #500, Somerville, MA 02143, USA
- Website
- tesseratherapeutics.com
- Employees
- 251-1K
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $11,891,248 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Gene writer genome engineering for in vivo car-t | Interior Business Center (DO) | $11,891,248 |
Quick answers
Is Tessera Therapeutics, Inc. registered in SAM.gov?
Yes. Tessera Therapeutics, Inc.'s SAM.gov registration is active through May 12, 2027.
How much has Tessera Therapeutics, Inc. received in federal contracts?
Federal contracts obligated $11,891,248 to Tessera Therapeutics, Inc. in fiscal year 2025.
How does Tessera Therapeutics, Inc. rank among federal contractors?
Tessera Therapeutics, Inc. ranked #25 in PSC AN13 and #71 in PSC AN in FY2025.
What is Tessera Therapeutics, Inc.'s most recent federal award?
Tessera Therapeutics, Inc.'s most recent federal contract award is Gene writer genome engineering for in vivo car-t (140D042590015), from Interior Business Center (DO), on September 23, 2025.
On GovTribe
See Tessera Therapeutics, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors